U.S. Issues Cuba Health Alert as Illnesses Rise 
New York Declares Measles Disaster Emergency as Cases Surge 
3 clinical-grade skincare creams you really shouldn’t buy online 
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal 
Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal 
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise 
Hengrui Shares Rise on $2.6 Billion Novo Nordisk Obesity Drug Deal 
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial 
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies 
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak 
Add as a preferred source on Google
One of the deadliest diseases that continue to plague the world’s population is HIV/AIDS. A report reveals that scientists are now another step closer to developing a cure after tests on mice and monkeys proved to be successful.
A recent report reveals that researchers from Emory University in Atlanta, Georgia, and North Carolina University conducted tests on a drug named AZD5582 on lab monkeys that had HIV. The drug essentially forced the virus to react and then killed it, proving to be a success. As this method helped cure monkeys of HIV, then the results on humans would prove to be promising, once the human trials begin.
The researchers at Emory University conducted this study on 12 monkeys that were suffering from SIV, which is similar to HIV, and were treated with ART. The scientists then used the drug to force the virus out of hiding, and thus killed it when it appeared. The drug being used was practically safe; however, one monkey suffered a temporary fever and a loss of appetite.
As for the researchers at North Carolina University, they conducted the test using the same drug on mice that had human HIV cells and found it to be a success. All that is left for both groups of researchers is to combine their findings and start doing human trials for the potential HIV/AIDS cure. The best part of these studies is that despite using two different animals, the result turned out the same, and this breakthrough will, therefore, open up many possibilities in potential HIV/AIDS treatment. If the human trials also prove to be a success, then it will not be long before the disease is deemed curable for good.
In line with a breakthrough in HIV/AIDS treatment, three infectious disease experts have been assessing potential existing drugs that may help get rid of the virus. They did their assessment based on the criteria of why and where this cure would be needed and how they can make it happen. They noticed that most of the research being done towards HIV/AIDS was in places where the disease is not a leading ailment, and the number of cases would likely be much smaller. They then concluded that this should take into account the needs and economies of people who are in dire need of a cure.
